All starting materials were purchased from Sigma Aldrich (St. Louis, MO, USA), unless otherwise noted. DSPE-PEG2000-maleimide was purchased from Avanti Polar Lipids (Alabaster, AL, USA). Cy7-amine was purchased from the Lumiprobe corporation (Hunt Valley, MD, USA), and Cy7 mono-N-hydroxysuccinimide ester was purchased from GE Healthcare Life Sciences (Pittsburgh, PA, USA). Materials for cell culture, which include fetal bovine serum (FBS, Gibco, Gaithersburg, MD USA), penicillin-streptomycin (Gibco, USA), 2-mercaptoethanol (Gibco, USA), and PBS (Gibco, USA) were purchased from Thermo Fisher Scientific (Waltham, MA, USA). Dulbecco’s Modified Eagle’s Medium (DMEM) was purchased from Sigma Aldrich. WEHI-274.1 murine monocytes (ATCC# CRL-1679) were purchased from ATCC (Manassas, VA, USA) and subjected to mycoplasma testing.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.